UK markets open in 1 hour 12 minutes
NIKKEI 225
39,488.80 +147.26 (+0.37%) HANG SENG
17,811.90 +95.43 (+0.54%) CRUDE OIL
82.31 +0.57 (+0.70%) GOLD FUTURES
2,335.10 -1.50 (-0.06%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,637.65 +382.18 (+0.79%)
Pharma Mar, S.A. (PHME.XC)
Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
At close: 05:18PM BST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 571.14M |
| Enterprise value | 451.68M |
| Trailing P/E | 709.00 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.82 |
| Price/book (mrq) | 3.85 |
| Enterprise value/revenue | 2.34 |
| Enterprise value/EBITDA | 81.47 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.01 |
| 52-week change 3 | 30.01% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 42.54 |
| 52-week low 3 | 32.72 |
| 50-day moving average 3 | 42.54 |
| 200-day moving average 3 | 38.71 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 17.47M |
| Implied shares outstanding 6 | 18.69M |
| Float 8 | 13.71M |
| % held by insiders 1 | 21.39% |
| % held by institutions 1 | 7.76% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.65 |
| Forward annual dividend yield 4 | 1.53% |
| Trailing annual dividend rate 3 | 0.65 |
| Trailing annual dividend yield 3 | 1.53% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 1,083.33% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 12 Jun 2024 |
| Last split factor 2 | 1:12 |
| Last split date 3 | 22 Jul 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 1.25% |
| Operating margin (ttm) | -11.32% |
Management effectiveness
| Return on assets (ttm) | -0.98% |
| Return on equity (ttm) | 0.99% |
Income statement
| Revenue (ttm) | 162.14M |
| Revenue per share (ttm) | 8.84 |
| Quarterly revenue growth (yoy) | 11.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -2.66M |
| Net income avi to common (ttm) | 2.03M |
| Diluted EPS (ttm) | 0.06 |
| Quarterly earnings growth (yoy) | 63.00% |
Balance sheet
| Total cash (mrq) | 159.72M |
| Total cash per share (mrq) | 9.06 |
| Total debt (mrq) | 40.26M |
| Total debt/equity (mrq) | 20.89% |
| Current ratio (mrq) | 2.62 |
| Book value per share (mrq) | 10.97 |
Cash flow statement
| Operating cash flow (ttm) | -11.81M |
| Levered free cash flow (ttm) | -23.19M |
© 2024 Yahoo. All rights reserved.